DE60229971D1 - Zubereitungen zur reizhemmenden rosacea-behandlung - Google Patents
Zubereitungen zur reizhemmenden rosacea-behandlungInfo
- Publication number
- DE60229971D1 DE60229971D1 DE60229971T DE60229971T DE60229971D1 DE 60229971 D1 DE60229971 D1 DE 60229971D1 DE 60229971 T DE60229971 T DE 60229971T DE 60229971 T DE60229971 T DE 60229971T DE 60229971 D1 DE60229971 D1 DE 60229971D1
- Authority
- DE
- Germany
- Prior art keywords
- rosacea
- treating
- components
- skin
- irritative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001303601 Rosacea Species 0.000 title abstract 7
- 201000004700 rosacea Diseases 0.000 title abstract 7
- 230000000622 irritating effect Effects 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- 241000124001 Alcyonacea Species 0.000 abstract 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 235000009569 green tea Nutrition 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 abstract 1
- 229940033329 phytosphingosine Drugs 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 229930007845 β-thujaplicin Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/971,561 US6680062B2 (en) | 2001-10-05 | 2001-10-05 | Anti-irritating rosacea treatment |
PCT/US2002/029722 WO2003030813A2 (en) | 2001-10-05 | 2002-09-18 | Anti-irritating rosacea treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60229971D1 true DE60229971D1 (de) | 2009-01-02 |
Family
ID=25518547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60229971T Expired - Lifetime DE60229971D1 (de) | 2001-10-05 | 2002-09-18 | Zubereitungen zur reizhemmenden rosacea-behandlung |
Country Status (9)
Country | Link |
---|---|
US (1) | US6680062B2 (de) |
EP (1) | EP1441685B1 (de) |
JP (2) | JP3921202B2 (de) |
AT (1) | ATE414527T1 (de) |
AU (1) | AU2002334601B2 (de) |
CA (1) | CA2461941C (de) |
DE (1) | DE60229971D1 (de) |
ES (1) | ES2316647T3 (de) |
WO (1) | WO2003030813A2 (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7314634B2 (en) * | 2002-02-22 | 2008-01-01 | Steven Hernandez | Use of polyphenols to treat skin conditions |
US7851477B2 (en) * | 2003-05-22 | 2010-12-14 | L'oreal | Method for the treatment of skin |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
US20050020600A1 (en) | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
US20050112078A1 (en) * | 2003-11-13 | 2005-05-26 | Sekhar Boddupalli | Plant-derived protein extract compositions and methods |
WO2005067627A2 (en) * | 2004-01-07 | 2005-07-28 | E-L Management Corporation | Cosmetic composition and method for retarding hair growth |
US7812049B2 (en) * | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
AU2005203301A1 (en) * | 2004-07-30 | 2006-02-16 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
DE102005005486A1 (de) * | 2005-02-04 | 2006-08-17 | Schwan-Stabilo Cosmetics Gmbh & Co. Kg | Zubereitung, insbesondere kosmetische Zubereitung sowie ihre Herstellung und Verwendung |
WO2006134160A2 (en) * | 2005-06-17 | 2006-12-21 | Symrise Gmbh & Co. Kg | Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives) |
FR2894821B1 (fr) * | 2005-12-15 | 2008-02-29 | Galderma Res & Dev | Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations |
EP1986665B1 (de) * | 2006-01-19 | 2018-05-02 | TerraVia Holdings, Inc. | Aus mikroalgen stammende zusammensetzungen zur verbesserung der gesundheit und des erscheinungsbilds der haut |
US8298548B2 (en) | 2007-07-18 | 2012-10-30 | Solazyme, Inc. | Compositions for improving the health and appearance of skin |
US20070166266A1 (en) * | 2006-01-19 | 2007-07-19 | Solazyme, Inc. | Methods and compositions for improving the health and appearance of skin |
US8277849B2 (en) * | 2006-01-19 | 2012-10-02 | Solazyme, Inc. | Microalgae-derived compositions for improving the health and appearance of skin |
US20090274736A1 (en) * | 2006-01-19 | 2009-11-05 | Solazyme Inc. | Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration |
US20070191303A1 (en) * | 2006-01-19 | 2007-08-16 | Solazyme, Inc. | Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions |
US7381433B1 (en) * | 2007-01-08 | 2008-06-03 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing an extract of a primula denticulata and use thereof |
CA2749750C (en) * | 2008-04-15 | 2014-01-28 | Immanence Integrale Dermo Correction Inc. | Skin care compositions and methods of use thereof |
EP2116237A1 (de) * | 2008-08-05 | 2009-11-11 | Polichem SA | Zusammensetzungen enthaltend Chitosan und Dicarboxysäure zur Behandlung von Rosacea |
US8927522B2 (en) | 2008-10-14 | 2015-01-06 | Solazyme, Inc. | Microalgal polysaccharide compositions |
WO2010054322A1 (en) | 2008-11-07 | 2010-05-14 | Solazyme, Inc. | Cosmetic compositions comprising microalgal components |
EP2329849B1 (de) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Kombination aus einem Alpha-2-Adrenozeptor-Agonisten und einem nichtsteroidalen entzündungshemmenden Mittel zur Behandlung oder Prävention einer Entzündungskrankheit der Haut |
US8394800B2 (en) * | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
CN102985091B (zh) | 2010-03-03 | 2016-11-23 | 新科蒂斯公司 | 使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法 |
US9180112B2 (en) * | 2010-03-23 | 2015-11-10 | Ermis Labs, LLC | Dermal compositions containing gorgonian extract |
DK2552449T3 (en) | 2010-03-26 | 2017-06-19 | Galderma Res & Dev | COMPOSITIONS INCLUDING BRIMONIDINE FOR TREATMENT OF ERYTHEM |
KR20150058551A (ko) | 2010-03-26 | 2015-05-28 | 갈데르마 리써어치 앤드 디벨로프먼트 | 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물 |
US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
CA2814952C (en) | 2010-10-21 | 2016-05-10 | Galderma S.A. | Brimonidine gel compositions and methods of use |
KR101821942B1 (ko) | 2010-12-30 | 2018-01-24 | 마리 케이 인코포레이티드 | 다목적 화장품 조성물 |
US10647668B2 (en) | 2011-01-03 | 2020-05-12 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactant and associated method of use |
US8933119B2 (en) | 2011-01-03 | 2015-01-13 | The William M. Yarbrough Foundation | Method for treating phytophotodermatitis |
US11407713B2 (en) | 2011-01-03 | 2022-08-09 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
US9962361B2 (en) | 2011-01-03 | 2018-05-08 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
US10308599B2 (en) | 2011-01-03 | 2019-06-04 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
US10273205B2 (en) | 2011-01-03 | 2019-04-30 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms |
US11279674B2 (en) | 2011-01-03 | 2022-03-22 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactant and associated method of use |
US10640464B2 (en) | 2011-01-03 | 2020-05-05 | The William M. Yarbrough Foundation | Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
US8865765B2 (en) | 2011-01-12 | 2014-10-21 | The William M. Yarbrough Foundation | Method for treating eczema |
US9532969B2 (en) | 2011-02-08 | 2017-01-03 | The William M. Yarbrough Foundation | Method for treating psoriasis |
WO2013016072A1 (en) | 2011-07-22 | 2013-01-31 | Allergan, Inc. | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
CN103889417A (zh) | 2011-10-19 | 2014-06-25 | 高德美国际公司 | 减少与全身使用5型磷酸二脂酶抑制剂有关的面部潮红的方法 |
US9283217B2 (en) | 2011-11-10 | 2016-03-15 | Allergan, Inc. | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
UA109359C2 (xx) | 2011-11-10 | 2015-08-10 | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
US10080734B2 (en) | 2012-07-26 | 2018-09-25 | The William M. Yarbrough Foundation | Method for treating autism and other neurodevelopmental disorders |
WO2014018874A1 (en) | 2012-07-26 | 2014-01-30 | The William M. Yarbrough Foundation | Method for treating skin cancer |
US10434082B2 (en) | 2012-07-26 | 2019-10-08 | The William M. Yarbrough Foundation | Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms |
US9839621B2 (en) | 2012-07-26 | 2017-12-12 | The William M. Yarbrough Foundation | Method for treating bladder cancer |
US9949943B2 (en) * | 2012-07-26 | 2018-04-24 | The William M. Yarbrough Foundation | Method for treating neurodegenerative diseases |
US10441561B2 (en) | 2012-07-26 | 2019-10-15 | The William M. Yanbrough Foundation | Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer |
US10434081B2 (en) | 2012-07-26 | 2019-10-08 | The William M. Yarbrough Foundation | Inhibitors of macrophage migration inhibitory factor |
US10335387B2 (en) | 2012-07-26 | 2019-07-02 | The William M. Yarbrough Foundation | Method for treating infectious diseases with isothiocyanate functional compounds |
US9861645B2 (en) | 2012-12-28 | 2018-01-09 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
WO2014186395A1 (en) | 2013-05-15 | 2014-11-20 | Solazyme, Inc. | Cosmetic compositions comprising microalgal oil |
WO2016007601A1 (en) | 2014-07-11 | 2016-01-14 | Mary Kay Inc. | Pore minimizer |
GB2528482A (en) * | 2014-07-23 | 2016-01-27 | Skintech Life Science Ltd | Pharmaceutical agent |
MX2020009161A (es) * | 2018-03-09 | 2022-10-13 | Ocusoft Inc | Composiciones topicas para el cuidado de la piel. |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3855525T2 (de) | 1987-06-18 | 1997-04-10 | Kureha Chemical Ind Co Ltd | Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS. |
US5306486A (en) | 1993-03-01 | 1994-04-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic sunscreen composition containing green tea and a sunscreen |
FR2732221B1 (fr) | 1995-03-28 | 1997-04-25 | Oreal | Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue |
US5624911A (en) | 1995-06-07 | 1997-04-29 | The Regents Of The University Of California | Ether derivatives of pseudopterosin |
IL114267A0 (en) | 1995-06-22 | 1995-10-31 | Univ Ben Gurion | Antiviral agents |
WO1997009307A1 (en) | 1995-09-01 | 1997-03-13 | Gist-Brocades B.V. | Retinoylamide based derivatives of sphingoid bases |
US5885595A (en) | 1996-05-13 | 1999-03-23 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic composition with a retinol fatty acid ester |
US5811114A (en) * | 1996-06-12 | 1998-09-22 | E-L Management Corp. | Stabilized hinokitiol and compositions containing same |
US5728732A (en) | 1996-11-27 | 1998-03-17 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin treatment with salicylic acid esters and retinoids |
CN1191058C (zh) * | 1997-09-12 | 2005-03-02 | 普罗克特和甘保尔公司 | 皮肤或毛发用清洁及调理用品 |
EP0975325B1 (de) | 1997-12-05 | 2003-09-17 | Cosmoferm B.V. | Zusammensetzungen, enthaltend eine kombination aus freier sphingoid-base und ceramide sowie deren verwendung |
US5972993A (en) | 1998-03-20 | 1999-10-26 | Avon Products, Inc. | Composition and method for treating rosacea and sensitive skin with free radical scavengers |
EP1093525A1 (de) | 1998-07-03 | 2001-04-25 | Cosmoferm B.V. | Sphingoid basen herstellende verbesserte mikrobielle stamme |
US5952372A (en) | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
-
2001
- 2001-10-05 US US09/971,561 patent/US6680062B2/en not_active Expired - Lifetime
-
2002
- 2002-09-18 CA CA2461941A patent/CA2461941C/en not_active Expired - Fee Related
- 2002-09-18 DE DE60229971T patent/DE60229971D1/de not_active Expired - Lifetime
- 2002-09-18 JP JP2003533847A patent/JP3921202B2/ja not_active Expired - Fee Related
- 2002-09-18 AU AU2002334601A patent/AU2002334601B2/en not_active Ceased
- 2002-09-18 WO PCT/US2002/029722 patent/WO2003030813A2/en active Application Filing
- 2002-09-18 ES ES02800840T patent/ES2316647T3/es not_active Expired - Lifetime
- 2002-09-18 AT AT02800840T patent/ATE414527T1/de not_active IP Right Cessation
- 2002-09-18 EP EP02800840A patent/EP1441685B1/de not_active Expired - Lifetime
-
2006
- 2006-08-22 JP JP2006225842A patent/JP2006306899A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2461941A1 (en) | 2003-04-17 |
JP2005508936A (ja) | 2005-04-07 |
ATE414527T1 (de) | 2008-12-15 |
US20030068343A1 (en) | 2003-04-10 |
WO2003030813A2 (en) | 2003-04-17 |
ES2316647T3 (es) | 2009-04-16 |
EP1441685A2 (de) | 2004-08-04 |
AU2002334601B9 (en) | 2003-04-22 |
EP1441685A4 (de) | 2007-10-31 |
JP2006306899A (ja) | 2006-11-09 |
EP1441685B1 (de) | 2008-11-19 |
AU2002334601B2 (en) | 2007-01-25 |
JP3921202B2 (ja) | 2007-05-30 |
CA2461941C (en) | 2011-07-26 |
US6680062B2 (en) | 2004-01-20 |
WO2003030813A3 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60229971D1 (de) | Zubereitungen zur reizhemmenden rosacea-behandlung | |
BRPI0006634B8 (pt) | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios | |
TW200509956A (en) | Compositions and methods for treatment of rosacea | |
ME02785B (me) | Humana anti-ngf neutrališuća antitela kao selektivni inhibitori ngf signalnog puta | |
BRPI0408476A (pt) | métodos para melhorar a qualidade da pele | |
ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
WO2007046097A3 (en) | Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof | |
BR0315598A (pt) | Anticorpos neutralizantes contra gdf-8 e usos dos mesmos | |
MY160153A (en) | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds | |
DE60237115D1 (de) | Synergistische Kombination von (-) -Gossypol mit Docetaxel oder Paclitaxel zur Behandlung von Krebs. | |
ATE536185T1 (de) | Verfahren zur abschwächung von reaktionen auf hautreizende mittel | |
SG163600A1 (en) | Methods for the treatment of muscle loss | |
WO2002040702A3 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
BR0213100A (pt) | Combinações para o tratamento de distúrbios imuniinflamatórios | |
ME00226B (me) | Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade | |
DE602004017871D1 (de) | Zubereitungen zur behandlung von arthritischen erscheinungen | |
NO20061236L (no) | Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton | |
HUP0304077A2 (hu) | A bőr öregedése elleni gyógyászati és kozmetikai készítmények | |
ATE318610T1 (de) | Orale zusammensetzungen zur behandlung von kopfhauterkrankungen | |
AR004326A1 (es) | Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista. | |
TW200724150A (en) | Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients | |
BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
DE60134002D1 (de) | Topische zusammensetzungen zur transdermalen gabe von niacin prodrugs sowie verfahren zur behandlung von hyperlipidämie | |
WO2003092645A3 (fr) | Composition cosmetique comprenant des mono- ou poly-saccharides | |
ATE326947T1 (de) | Thixotropes nasenspray |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |